Table 1 Baseline characteristics of subjects receiving Placebo, Phyllanthus emblica 250 mg and Phyllanthus emblica 500 mg
Parameter | Placebo (A) (n = 18) | Phyllanthus emblica 250 mg (B) (n = 20) | Phyllanthus emblica 500 mg (C) (n = 21) | |
|---|---|---|---|---|
Age in Yrs. | 56.89 ± 7.39 | 57.45 ± 7.44 | 57.24 ± 8.94 | |
Gender (M/F) | 14/4 | 14/6 | 15/6 | |
Bodyweight (Kg) | 78.17 ± 5.94 | 78.9 ± 6.61 | 78.9 ± 4.87 | |
Height (cm) | 161.17 ± 2.77 | 162.20 ± 3.53 | 162.14 ± 2.83 | |
BMI (Kg/m2) | 30.11 ± 1.72 | 30.02 ± 1.66 | 30.05 ± 1.70 | |
BMI (kg/m2) | < 30 | 5 (28%) | 7 (35%) | 6 (29%) |
>  30 | 13 (72%) | 13 (65%) | 15 (71%) | |
SBP (mmHg) | < 130 | 5 (28%) | 7 (35%) | 9 (43%) |
> 130 | 13 (72%) | 13 (65%) | 12(57%) | |
DBP (mmHg) | <  85 | 10(56%) | 12(60%) | 8(38%) |
>  85 | 8 (44%) | 8 (40%) | 13 (62%) | |
FPG (mg /dL) | < 100 | 13 (72%) | 11 (55%) | 8(38%) |
> 100 | 5 (28%) | 9 (45%) | 13 (62%) | |